Clinical Effect of L-carnitine on Carnitine Deficiency in Maintenance Hemodialysis Patients

王英,王梅,潘缉圣,陈香美,李文歌,范敏华,张爱华
DOI: https://doi.org/10.3969/j.issn.1001-6821.2003.04.004
2003-01-01
Abstract:OBJECTIVE: To observe the effects of L-carnitine on carnitine deficiency in maintenance hemodialysis patients. METHODS: The multicenter, randomized, controlled and single blind trial was carried out. One hundred forty-seven maintenance hemodialysis patients were divided into two groups: test group received L-carnitine of Demo and control group received L-carnitine of Sigma-Tau (1g, intravenous injection) at the end of hemodialysis 2 times a week for 12 weeks. RESULTS: Intravenous treatment of both L-carnitine can significantly increased plasma free carnitine level of the patients(P0.01). Their exercise capacity was increased. And symptoms of anorexia, weakness, muscle cramps and intra-dialytic hypotension were improved significantly as well. There was no significant difference between two groups. This treatment may work on abnormality of lipids metabolism and r-HuEPO hyporesponsiveness. CONCLUSION: Intravenous treatment of L-carnitine was safe and effective on carnitine deficiency in maintenance hemodialysis patients.
What problem does this paper attempt to address?